Trial record 2 of 8 for:
ponatinib | Leukemia, Myeloid | Italy
Cardiovascular Assessment of Ponatinib as Third Line Treatment in Chronic Phase Chronic Myeloid Leukemia (CarPAs)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04709731 |
|
Recruitment Status :
Not yet recruiting
First Posted : January 14, 2021
Last Update Posted : February 3, 2021
|
Sponsor:
Associazione Italiana Pazienti Leucemia Mieloide Cronica
Information provided by (Responsible Party):
Associazione Italiana Pazienti Leucemia Mieloide Cronica
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | October 31, 2024 |
| Estimated Study Completion Date : | April 1, 2025 |